Evaluation of Antineoplastic Delayed-Type Hypersensitivity Skin Reactions In Vitro
Delayed-type hypersensitivity (DTH) is caused by a broad number of drugs used in clinic, and antineoplastic drugs show an elevated proportion of DTH, which potentially affects the quality of life of patients. Despite the serious problem and the negative economic impact deriving from market withdrawa...
Saved in:
Main Authors: | Inés Roger (Author), Paula Montero (Author), Antonio García (Author), Javier Milara (Author), Pilar Ribera (Author), Jose Alejandro Pérez-Fidalgo (Author), Julio Cortijo (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phosphodiesterase 4 is overexpressed in keloid epidermal scars and its inhibition reduces keratinocyte fibrotic alterations
by: Javier Milara, et al.
Published: (2024) -
Targeting IL-11 system as a treatment of pulmonary arterial hypertension
by: Javier Milara, et al.
Published: (2023) -
Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis
by: Cristina Estornut, et al.
Published: (2022) -
Delayed hypersensitivity reaction of hyaluronic acid filler (VCY-20)
by: Christopher del Rio-Martinez, et al.
Published: (2023) -
Cystic fibrosis: desensitization in delayed hypersensitivity reactions to elexacaftor/tezacaftor/ivacaftor
by: L. Gómez-Ganda, et al.
Published: (2024)